Zeracizumab Is an Experimental Angiogenesis Inhibitor Targeting Vascular Endothelial Growth

question 107

Multiple Choice

Zeracizumab is an experimental angiogenesis inhibitor targeting vascular endothelial growth factor that is being tested for the treatment of advanced, chemotherapy-naive, non-squamous non-small cell lung cancer (NSCLC) .  Part of the drug company's evaluation process is to analyze the 1-year survival after treatment to determine the clinical efficacy of the experimental treatment.  The results are given in the table below. Which of the following best represents the number needed to harm for the zeracizumab-containing regimen?

• A)2
• B)25
• C)40
• D)72
• E)94

---

Definitions:

Regret Aversion

A psychological effect where individuals avoid making decisions that could result in action-based regret, affecting investment choices and risk-taking behaviors.

Short-Term Losses

Financial losses realized on the sale or exchange of an asset held for one year or less.

Making a Decision

The cognitive process of selecting a course of action from among multiple alternatives.